This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
The delegation's visit covered a wide range of topics
WINLEVI works differently from any other topical acne treatment
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated
